Dr. Dunbar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
39th And Market Streets
Phi Suite 2a
Philadelphia, PA 19104Phone+1 215-662-9990- Is this information wrong?
Education & Training
- Virginia Commonwealth University Health SystemResidency, Internal Medicine, 1997 - 2000
- Virginia Commonwealth University School of MedicineClass of 1997
Certifications & Licensure
- PA State Medical License 2003 - 2024
- VA State Medical License 1998 - 2004
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study Start of enrollment: 2008 Jun 01
- Advancing Niacin by Inhibiting Flushing (ANTI-FLUSH) Start of enrollment: 2009 Feb 01
- Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis Start of enrollment: 2010 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsEstimated Atherosclerotic Cardiovascular Disease Risk Score: An Automated Decision Aid for Statin Therapy.Maureen Sampson, Anna Wolska, Marcelo Amar, Masako Ueda, Richard Dunbar, Daniel Soffer, Alan T Remaley> ;Clinical Chemistry. 2022 Oct 6
- 29 citationsInhibition of Angiopoietin-Like Protein 3 With Evinacumab in Subjects With High and Severe HypertriglyceridemiaZahid Ahmad, Robert Pordy, Daniel J. Rader, Daniel Gaudet, Shazia Ali, Claudia Gonzaga-Jauregui, Manish P Ponda, Brad Shumel, Poulabi Banerjee, Richard L. Dunbar> ;Journal of the American College of Cardiology. 2021 Jul 13
- 2 citationsA retrospective analysis of clinical use of alirocumab in lipoprotein apheresis patients.Anne C. Goldberg, Richard L. Dunbar, Linda C. Hemphill, Stephan P. Babirak, Gerald Wilson, Michael Wooten, Mohamed Iydroose, Kelley C Dacus, Heather M. Minchew, Julie ...> ;Journal of Clinical Lipidology. 2020 Aug 18
- Join now to see all
Press Mentions
- Injectable Regeneron Biologic Therapy Reduces Triglycerides, CholesterolNovember 15th, 2016
- Injectable Biologic Therapy Dramatically Reduces TriglyceridesNovember 14th, 2016
Grant Support
- Niacin'S Effect On Fatty Acids And Inflammatory Markers (Nefa-Im)National Heart, Lung, And Blood Institute2009–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: